Observational registry for MED-EL hearing devices
Official title: MED-EL HEARING SOLUTIONS (MEHS): AN OBSERVATIONAL STUDY
Run by MED-EL Elektromedizinische Geräte GmbH · NCT05668338 · Data updated 2026-11-12
This study collects information from children and adults using MED-EL hearing devices to see how well they work and how they improve people's lives.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | MED-EL Elektromedizinische Geräte GmbH Industry-sponsored |
| Locations | 8 sites (Bochum and 7 other locations) |
| Status | Recruiting |
| Started | June 26, 2017 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT05668338 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children and adults who are receiving or planning to receive MED-EL hearing devices, whether implantable or non-implantable.
✕Probably not a fit
Patients who do not meet the inclusion criteria or have conditions that may complicate their participation may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry collects anonymized clinical data from children and adults using MED-EL hearing devices. It aims to gather information on device use, auditory performance, quality of life, and health-related utilities through standardized tests and questionnaires. Participants will be evaluated before implantation or device activation and at follow-up intervals, allowing for comprehensive data analysis on the effectiveness of various hearing solutions. The study is designed to generate hypotheses that can inform future research and clinical practices.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of hearing device effectiveness and improve patient outcomes.
How similar studies have gone: Other observational studies on hearing devices have shown promise in improving patient outcomes, suggesting that this approach could be beneficial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * For children and adults receiving an implant: Subjects submitted or planned to be submitted to unilateral or bilateral implantation, using simultaneous or sequential procedures. * For children and adults receiving a non-implantable device: Subjects submitted or planned to be submitted to unilateral or bilateral treatment with a non-implantable device from MED-EL. * Unilateral, bilateral or bimodal users (children and adults) of cochlear implants (CIs), electric-acoustic devices, bone conduction implants, middle ear implants or any other implantable or non-implantable hearing solution from MED-EL. * Signed written informed consent for data collection for Registry purposes. Exclusion Criteria: * Lack of compliance with any inclusion criteria. * Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the Registry procedures
Where it's running
-
Katholisches Klinikum Bochum
Bochum, Germany Recruiting -
Universitätsklinik Carl Gustav Carus - Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde
Dresden, Germany Recruiting -
Universitätsklinikum der Goethe-Universität
Frankfurt, Germany Recruiting -
Sektion Otologie und Neuro-Otologie UNI-Klinikum Heidelberg
Heidelberg, Germany Recruiting -
Klinikum der Universität München Campus Großhadern
München, Germany Recruiting -
Evangelisches Krankenhaus Oldenburg
Oldenburg, Germany Recruiting
Show 2 more locations
-
Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie "Otto Körner"
Rostock, Germany Recruiting -
Universitätsklinikum Tübingen, Klinik für Hals-, Nasen- u. Ohrenheilkunde, Plastische Operationen
Tübingen, Germany Recruiting
Study contacts
- Principal investigator: Daniel Polterauer-Neuling, Dr. — Klinikum der Universität München Campus Großhadern
- Study coordinator: Jasmine Rinnofner
- Email: jasmine.rinnofner@medel.com
- Phone: +43 57 788 1694
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
WhatsApp AI support vs paper support for first-time hearing aid users
This study tests whether a WhatsApp-based AI support program helps adults with new hearing aids in LMIC communities use and feel confident about their devices better than a paper pamphlet.
-
Hearing and Brain Development in Children and Teens
This observational study tests how hearing care paths (like hearing aids, cochlear implants, brainstem implants, gene therapy, or no intervention) relate to hearing, speech, language, and brain development in kids and teens, with a normal-hearing group for comparison.
-
Web-based auditory training with easy versus hard task settings to improve speech and listening
This project will test whether easy or hard versions of a web-based auditory training program help adults with hearing loss improve speech understanding and everyday listening.
-
Long-term hearing and speech outcomes after cochlear implants
This project will see if cochlear implants improve hearing, speech understanding, and quality of life in Mandarin-speaking patients of all ages before and after surgery.
-
Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder
This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.
-
Add Pedmark to cisplatin chemotherapy to prevent hearing loss in men with stage II–III metastatic testicular germ cell tumors
We will test whether adding Pedmark to cisplatin chemotherapy reduces hearing damage in men with stage II–III metastatic testicular germ cell tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.